Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 700
Selected: 0
NCT IDTitle
NCT00202020Efficacy and Safety Study of Cilostazol to Prevent Reoccurrence of Stroke
NCT01646827An Open Label Study of Aripiprazole Intramuscular Injection in Subjects With Schizophrenia
NCT01227512Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia
NCT01184807Phase 1, Dose-escalation Trial of OPB-51602 in Patients With Advanced Solid Tumors
NCT03324581The Safety and Efficacy of OPC-64005 in the Treatment of Adult Attention-deficit/Hyperactivity Disorder
NCT06926829A Long-term Trial of EB-1020 in Adult Patients With ADHD
NCT01590901Pharmacokinetics and Safety Study of Probucol by Multiple Administration in Healthy Male Subjects
NCT05363839To Assess the Safety, Tolerability and Pharmacokinetics of ACH-000029 in Healthy Subjects
NCT01876381A Phase 2, Multi-center, Open-label, Dose-finding Trial to Investigate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of OPC-41061 in Patients With Chronic Renal Failure Undergoing Hemodialysis or Hemodiafiltration
NCT05326230A Clinical Study of the Paradise™ Renal Denervation System in Patients With Hypertension (RADIANCE-HTN DUO)
NCT02054702Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Acute Schizophrenia
NCT04313153Trial Evaluating the Efficacy and Safety of Oral Vadadustat Once Daily (QD) and Three Times Weekly (TIW) for the Maintenance Treatment of Anemia in Hemodialysis Subjects Converting From Erythropoiesis-Stimulating Agents (ESAs)
NCT01942161A Short Treatment Study of Aripiprazole in Pediatric Patients With Schizophrenia
NCT03284177A Trial of C13-CAC Breath Test in PPI Resistant GERD Patients
NCT02573077An Observational Study Measuring Outcomes in Cancer Patients Treated for Moderate to Severe Hyponatremia in Italy
NCT01026584Efficacy and Safety of Aripiprazole in First Episode Psychosis
NCT04770285Trial to Evaluate the Effectiveness of a Digital Therapeutics in Adults Diagnosed With Major Depressive Disorder
NCT02847624Post-Marketing Surveillance Study of Tolvaptan in Patients With ADPKD
NCT00102479Aripiprazole Pharmacokinetics (PK) and Tolerability Study in Children and Adolescents
NCT01663662The Use of Tolvaptan to Prevent Renal Dysfunction in High Risk Patients With Heart Failure-Pilot Study
NCT02020278An Extension Follow-up Trial to Evaluate the Long-term Safety of Children and Adolescent Participants With Euvolemic or Hypervolemic Hyponatremia
NCT00845988Metabolic Effects of Switching to Aripiprazole in Patients With Bipolar Disorders
NCT00796562Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy
NCT01795547Aripiprazole Once-monthly Versus Paliperidone Palmitate in Adult Patients With Schizophrenia
NCT02360319Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics
NCT00321516Drug-drug Interaction Study of Aripiprazole and Lamotrigine in Patients With Bipolar Type I Disorder
NCT05615363A Dose-ranging Trial of OPC-131461 in Cardiac Edema (Congestive Heart Failure [CHF])
NCT01617447A Short Treatment Study of Aripiprazole in Pediatric Patients With Autistic Disorder
NCT04331132Tolvaptan add-on Therapy to Overcome Loop Diuretic Resistance in Acute Heart Failure With Renal Dysfunction
NCT01014416Pharmacokinetics/Pharmacodynamics (PK/PD) Characteristics of Tolvaptan Tablet in Korean Healthy Male
NCT03548584A Trial to Evaluate the Safety, Efficacy, and Tolerability of Brexpiprazole in Treating Agitation Associated With Dementia of the Alzheimer's Type
NCT05439148OPC-61815 in Healthy Chinese Male Subjects
NCT05418101A Study to Evaluate the Safety, PK and PD of VIS171 in Participants (Healthy and With Autoimmune Disease)
NCT02446132Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
NCT01129882An Open-Label, Multicenter, Rollover, Long-term Study of Aripiprazole Intramuscular Depot in Participants With Schizophrenia
NCT00741286Effect of Cilostazol in the Acute Lacunar Infarction Based on Pulsatility Index of Transcranial Doppler
NCT02006654Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With an Acetylcholinesterase Inhibitor
NCT02548845An Observational Study to Describe the Adherence to the SEOM Algorithm for the Treatment of Hyponatraemia in Spain
NCT01727726A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial
NCT01447576Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
NCT01973140Effects of Tolvaptan in Healthy Adults
NCT07770815Trial of Sibeprenlimab in Children and Adolescents With Immunoglobulin A Nephropathy (IgAN)
NCT06674291Registry on the Effectiveness and Safety of the 9-month MDR-END Treatment Regimen in Korean Patients with FQ-sensitive MDR-TB (MDR-END Registry)
NCT01228682Post-Authorisation Safety Study of Samsca (Tolvaptan) Used in Routine Medical Practice
NCT05667623To Demonstrate the Superiority of IMP (1% OPA-15406 Ointment) to the Vehicle in Adult Patients With AD
NCT04830215Brexpiprazole as Adjunctive Therapy in Adults With Major Depressive Disorder
NCT04408755Assessment of the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
NCT02237417Impact of Aripiprazole Once Monthly Medications on Changes in Brain Structure and Metabolism
NCT00428948Tolvaptan Phase 3 Efficacy and Safety Study in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
NCT03238326Safety and Tolerability of Open-Label Flexible-dose Brexpiprazole as Maintenance Treatment in Adolescents With Schizophrenia